Cargando…
No evidence for higher rates of hepatocellular carcinoma after direct-acting antiviral treatment: a meta-analysis
AIM: Hepatitis C virus (HCV) is the leading cause of hepatocellular carcinoma (HCC) in the United States. Achieving sustained viral response with interferon (IFN) treatment reduces the risk from 3%-5% to 0.5%-1% annually. Several studies reported unexpectedly high rates of HCC after treatment with d...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709867/ https://www.ncbi.nlm.nih.gov/pubmed/31453368 http://dx.doi.org/10.20517/2394-5079.2019.19 |